We made the important observation of a subset of early polyps with concurrent mutations in WNT, RTK-RAS, or p53 signaling pathways, and these lesions had higher mean MB than polyps lacking concurrent mutational defects in these colorectal cancer driver pathways (Fig. 3D). Here, TP53 is linked to colorectal cancer.